Accera Inc.

Accera, Inc. Appoints Dr. Thomas Werner President & CEO and Announces FDA Acceptance of IND Application for AC-1204 for Mild-to-Moderate Alzheimer's Disease

Older News

BROOMFIELD, Colorado, October 5, 2010 - Accera, Inc., a medical research and development company delivering breakthrough therapies for serious diseases such as Alzheimer's disease (AD), announced today that Thomas Werner, Ph.D., has been appointed President and CEO.

MORE..

Corporate
|
Products
|
About Me
|
Contact
|
Privacy Policy